Growth in pharmacovigilance rarely means dealing with more of the same. As medicines reach additional markets, safety information begins arriving through more sources: patients, healthcare professionals, local affiliates, patient support programs, medical literature, call centers, and digital platforms. The reports themselves may include structured forms, handwritten notes, medical records, emails, laboratory results, and supporting documents. They may also arrive in several languages.
For pharmacovigilance teams, the challenge isn’t simply processing a greater number of adverse event reports. It’s managing more information across more systems, formats, countries, and timelines while making sure the details needed for assessment remain clear.
At lower volumes, teams may be able to work around an inefficient process. Someone notices that two documents belong to the same case. A project manager manually corrects a missing reference number. A safety specialist follows up when terminology doesn’t match an earlier report. But as volumes increase, those small workarounds become harder to sustain.
More reports create more points of friction
A single adverse event case may involve several pieces of information. The initial report might arrive through a local affiliate. A hospital record may follow later. The patient may then respond to a follow-up questionnaire, while a healthcare professional submits additional clinical information in another language.
Each piece needs to remain connected to the correct case. Product names, symptoms, dosages, dates, and treatment details should be handled consistently. Any unclear or incomplete language must be identified rather than silently interpreted.
When these activities are managed through disconnected requests, safety teams may spend unnecessary time searching for files, resolving terminology differences, or checking whether every document has been returned.
The issue isn’t only inconvenience. Delays and fragmented information can make it harder for the people reviewing the case to see the full picture.
Language is part of the safety workflow
Translation is sometimes treated as an external step: content is sent out, translated, and returned. But adverse event information isn’t ordinary business content. A patient may describe a reaction using everyday language rather than a medical term. A healthcare professional may use an abbreviation that is familiar in one market but unclear in another. A handwritten note may contain an uncertain word or figure. Dates and dosage formats may differ between countries. The language process must preserve what was reported without adding certainty that isn’t present in the source.
It must also preserve context. A translated medical record is much more useful when the safety team can immediately see which case it belongs to, where it fits in the reporting timeline, and how it relates to other supporting documents. This is why multilingual work should be built into the wider pharmacovigilance process rather than managed as a collection of isolated translation tasks.
Scaling requires more than additional capacity
Hiring more people or sending more work to external providers may relieve immediate pressure, but it doesn’t automatically create a scalable process. If requests arrive without the correct references, priority levels, document types, or turnaround requirements, adding capacity can simply move the same confusion into a larger workflow. A more effective approach begins with consistent intake.
Each request should include the information needed to route and manage the work correctly. That may include the case reference, source language, market, content type, required turnaround, and any priority status assigned by the safety team. From there, work can follow defined pathways. Routine content may move through a standard process, while handwritten, medically complex, or unclear material receives additional specialist attention. Requests identified by the organization for urgent handling can be escalated according to agreed procedures. This reduces reliance on individual people spotting problems manually.
Use technology for the repeatable work
Technology can help pharmacovigilance teams manage growing multilingual volumes, particularly when it’s used for clearly defined tasks.
It can support:
- Request intake and routing
- Status and deadline tracking
- File and case-reference management
- Approved terminology
- Repeated-content identification
- Checks involving numbers, dates, formatting, or missing text
- Reporting on volume, turnaround, and exceptions
These tools can improve visibility and help teams identify where work is becoming delayed. They should not, however, be expected to make safety decisions. Questions involving seriousness, causality, expectedness, reportability, or the clinical meaning of a case remain with qualified pharmacovigilance professionals. The aim of technology is to reduce avoidable manual work so that people can focus on the decisions requiring their expertise.
Consistency becomes more important as volume grows
The same product names, medical concepts, and safety terms may appear across thousands of documents. Without terminology controls, different translators or teams may describe the same concept in different ways. Even where each translation is technically understandable, those differences can create additional review or make related information harder to compare.
Approved glossaries and translation memories can help maintain consistency across reports, follow-up correspondence, medical records, and other safety materials. But consistency should never mean forcing the source into standard language.
If a patient’s description is vague, the translation should preserve that uncertainty. If a source document contains conflicting information, the issue should be flagged. If handwriting is illegible, the translator should not guess. Specialist linguists understand that the goal is not to make every sentence sound polished. It is to communicate the meaning, detail, and level of certainty in the original.
Prepare for peaks before they happen
Pharmacovigilance demand is not always predictable. A product launch, entry into a new market, an updated safety communication, an expanded patient program, or a regulatory request can quickly increase case volumes. Less common languages may also appear unexpectedly in time-sensitive situations. A scalable process should account for these peaks before the pressure arrives. That means maintaining access to qualified linguists, agreeing on escalation procedures, forecasting likely language needs, and establishing how additional volume will be managed without weakening quality controls. It also means testing the process.
Teams should know how urgent requests are identified, how questions are raised, how supporting files remain connected, and how progress can be monitored when volumes rise.
Keep the patient behind the process in view
Pharmacovigilance discussions often focus on queues, turnaround times, systems, and capacity. Those measures matter, but every case begins with something that happened to a person. The purpose of a multilingual safety workflow is not simply to translate more content more quickly. It’s to help safety teams receive information that’s accurate, connected, and ready to review.
When language support is properly integrated into pharmacovigilance operations, organizations can increase capacity without losing sight of the details that may support follow-up, assessment, signal detection, regulatory reporting, and risk communication. As global safety information continues to grow, that connection between language and patient safety will become increasingly important.
Supporting scalable multilingual pharmacovigilance
BIG Language Solutions helps life sciences organizations manage multilingual safety information through secure workflows, specialist linguists, controlled terminology, technology-assisted processes, and human quality review.
From individual case documents and supporting medical records to follow-up correspondence and wider safety communications, we help teams manage growing demand while protecting the accuracy and context of the information they receive.
Is your current multilingual workflow equipped to handle growing safety volumes without losing accuracy, context, or control?
Contact BIG to discuss how multilingual workflows can support safer, more scalable pharmacovigilance operations.
